- Stocks
- Healthcare
- NASDAQ: PGNY

Price (delayed)

$49.88

Market cap

$4.35B

P/E Ratio

92.37

Dividend/share

N/A

EPS

$0.54

Enterprise value

$4.29B

Sector: Healthcare

Industry: Health Information Services

Progyny's gross profit has surged by 54% YoY and by 15% QoQ

The revenue has surged by 50% year-on-year and by 11% since the previous quarter

PGNY's quick ratio is down by 32% year-on-year and by 3.6% since the previous quarter

What are the main financial stats of PGNY

Market
Valuations
Earnings

Shares outstanding

87.22M

Market cap

$4.35B

Enterprise value

$4.29B

Price to earnings (P/E)

92.37

Price to book (P/B)

25.88

Price to sales (P/S)

12.4

EV/EBIT

501.09

EV/EBITDA

409.82

EV/Sales

12.44

Revenue

$344.86M

EBIT

$8.56M

EBITDA

$10.46M

Free cash flow

$35.17M

Per share
Balance sheet
Liquidity

EPS

$0.54

Free cash flow per share

$0.41

Book value per share

$1.93

Revenue per share

$4.02

TBVPS

$2.81

Total assets

$253.93M

Total liabilities

$86.98M

Debt

$8.32M

Equity

$166.95M

Working capital

$112.44M

Debt to equity

0.05

Current ratio

2.45

Quick ratio

2.38

Net debt/EBITDA

-5.92

Margins
Efficiency
Dividend

EBITDA margin

3%

Gross margin

20.3%

Net margin

13.5%

Operating margin

2.4%

Return on assets

22.8%

Return on equity

34.7%

Return on invested capital

14.6%

Return on capital employed

4.9%

Return on sales

2.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Progyny stock price performed over time

Intraday

-5.83%

1 week

4.5%

1 month

5.83%

1 year

116.96%

YTD

17.67%

QTD

12.06%

How have Progyny's revenue and profit performed over time

Revenue

$344.86M

Gross profit

$70.06M

Operating income

$8.35M

Net income

$46.46M

Gross margin

20.3%

Net margin

13.5%

Progyny's gross profit has surged by 54% YoY and by 15% QoQ

The revenue has surged by 50% year-on-year and by 11% since the previous quarter

PGNY's operating margin is down by 43% year-on-year and by 14% since the previous quarter

Progyny's operating income has decreased by 14% YoY and by 2.3% QoQ

What is Progyny's growth rate over time

What is Progyny stock price valuation

P/E

92.37

P/B

25.88

P/S

12.4

EV/EBIT

501.09

EV/EBITDA

409.82

EV/Sales

12.44

The EPS has grown by 42% since the previous quarter

PGNY's equity is up by 46% year-on-year and by 31% since the previous quarter

PGNY's price to book (P/B) is 46% higher than its last 4 quarters average of 18.8

PGNY's price to sales (P/S) is 57% higher than its last 4 quarters average of 8.4

The revenue has surged by 50% year-on-year and by 11% since the previous quarter

How efficient is Progyny business performance

The return on sales has surged by 168% year-on-year and by 150% since the previous quarter

The company's return on equity has surged by 139% YoY

PGNY's return on invested capital has surged by 113% year-on-year and by 87% since the previous quarter

What is PGNY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PGNY.

How did Progyny financials performed over time

PGNY's total assets is 192% more than its total liabilities

PGNY's total liabilities has surged by 141% year-on-year and by 16% since the previous quarter

PGNY's total assets has soared by 69% YoY and by 26% from the previous quarter

The company's debt is 95% lower than its equity

PGNY's equity is up by 46% year-on-year and by 31% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.